NeOnc Technologies Holdings, Inc. - Common Stock

Share · US64051A1016 · NTHI (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of NeOnc Technologies Holdings, Inc. - Common Stock

No Price

28.04.2026 20:00

Current Prices from NeOnc Technologies Holdings, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NTHI	USD	28.04.2026 20:00	4,31 USD	-0,30 USD -6,51 %
IEX	NTHI	USD	28.04.2026 19:59	4,31 USD	-0,30 USD -6,51 %

Share Float & Liquidity

Free Float 21,92 %

Shares Float 4,38 M

Shares Outstanding 20 M

Company Profile for NeOnc Technologies Holdings, Inc. - Common Stock Share

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.